Strategic Product
Development
Offering decades of strategic development experience,
global compliance, and therapeutic expertise to ensure
your promising therapy isn’t delayed by risk or limited resources.
Get Started
ePremier
eSource
Combining highly trained specialists and carefully
refined processes with our world-class technology.
Get Started
Global Regulatory
Consulting
Industry leaders with comprehensive submission
experience to strategically position your product.
Get Started
ePremier
Built for
CTN
We help the most innovative companies transform
life-changing ideas and breakthrough science into
new medical treatments.
LATEST INSIGHTS IN CLINICAL DEVELOPMENT

Leading the way

Our customers are highly innovative biopharmaceutical companies doing incredible things. It’s amazing and often very complex science, and we’ve positioned ourselves right in the middle of the action, supporting therapeutic areas where pioneers are doing the most exciting work.

events & webinars

EVENT

ACT Annual Meeting

Booth #223

November 12, 2023 – November 15, 2023

EVENT

Medica

November 13, 2023 – November 16, 2023

WEBINAR

The Voice of the Hematological Malignancy Patient: Are You Listening?

November 16, 2023

LATEST RESOURCES

BLOG

5 Stepping Stones to the Future State of Rare Disease Clinical Development

By Leslie Wetherell
November 14, 2023

BLOG

5 Stepping Stones to the Future State of Rare Disease Clinical Development

By Leslie Wetherell
November 14, 2023

BLOG

5 Stepping Stones to the Future State of Rare Disease Clinical Development

By Leslie Wetherell
November 14, 2023

CTN Insights

Customized services for each program, with tailored processes designed to meet highly specific needs. We’ve learned a lot about what works and what doesn’t. Browse the latest learnings and insights from our clinical development professionals.

document thumb

Oncology & Hematology

Streamlining Regulatory Submissions for a Novel Advanced Therapy Medicinal Product Trial

celltherapy

Cell & Gene Therapy

Site Selection, Manufacturing, and Long-Term Follow-Up in a Transition Phase 1/2 Gene Therapy Trial

document thumb

Neuroscience

Conclusive & Positive Results Delivered Ahead of Time – By Eight Months

Rare Disease

Delivering the Global Expertise Required to Coordinate a Pediatric Gene Therapy Trial

Connect with us

Ready to get started? So are we. Drop us a line to learn more about how we can help.

Contact Us Now
43gV